Biofortuna Ltd appoints new chairman to lead next phase of growth
Ian has spent his business career in life sciences. He was founder and CEO of Biotrace International plc, a leading provider of rapid microbial testing systems and reagents, which was sold to 3M for $100M. Ian is currently non-executive chairman of Celsis Group Ltd and Cyprotex PLC, both Harwood Private Equity investments, a company for which Ian acts as an operational advisor. Ian has served on the boards of various public and private companies in strategic consultancy and business development capacities, including Evans Analytical Group, MyCelx Technologies Corporation and AOI Medical Inc.
Most read news
Other news from the department people
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.